THE start of next month will see
the PBS listing of Actemra
(tocilizumab), which is the first
biologic treatment for rheumatoid
arthritis to be clinically superior to
methotrexate as monotherapy.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 21 Jul 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 10
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.